← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV21행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTPhase 1
19 (T2, 19, 19(T2)28z1xx TRAC T cell)
GlaxoSmithKline·B-Cell Lymphoma
ORR 100%
Overview
Program
19(T2)28z1xx TRAC T cell
Overview
Company
GlaxoSmithKline
Overview
Modality
CGT
Overview
Target
B-Cell Lymphoma
Overview
Indication
B-Cell Lymphoma; Large B-cell Lymphoma
Overview
Phase
PHASE_1
Overview
Status
RECRUITING
MoA
Mechanism
ADC and SDC of 1 rat study with liver fibrosis induced by biliary duct ligation (BDL), and 3 sets of human liver fibrosis data
MoA
Biomarker
biomarkers, enhanced trial matching, and scalable cohort identification
PK/PD
Species
Rat
PK/PD
Animal (cat.)
Human, Rat, In vitro
PK/PD
Experiment
pd
Toxicology
Species
Rat
Toxicology
Animal (cat.)
Human, Rat, In vitro
Toxicology
Major finding
Therapeutic potential of crude protein extracts from two Egyptian freshwater snails Lanistes carinatus and Bellamya unicolor.. Freshwater snails are emerging sources of bioactive molecules with potential biomedical and therapeutic relevance. This study evaluated crude protein extracts from two Egyptian freshwater snails, Lanistes carinatus and Bellamya unicolor, for antioxidant enzymes, antimicrob…
Clinical
Primary efficacy
ORR 100%
Clinical
ORR
100%
Clinical
Result source
ClinicalTrials.gov NCT04750941
Clinical
Data Tier / Score
A · 58
Clinical
Program phase
PHASE_1
Clinical
Clinical sync
2026년 7월 4일 (9일 전)